Technical Analysis for HCWB - HCW Biologics Inc.

Grade Last Price % Change Price Change
C 0.95 -13.89% -0.15
HCWB closed down 13.89 percent on Wednesday, November 20, 2024, on 65 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Gapped Down Weakness 0.00%
New Uptrend Bullish -13.89%
Jack-in-the-Box Bullish Bullish Swing Setup -13.89%
Volume Surge Other -13.89%

   Recent Intraday Alerts

Alert Time
Gapped Down (Full) about 22 hours ago
200 DMA Support about 22 hours ago
Down 5% about 22 hours ago
Down 3% about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

HCW Biologics Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company is involved in developing HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. It is also developing HCW9218 as an injectable immunotherapeutic for patients with pancreatic, breast, ovarian, colorectal, and prostate cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Acute Myeloid Leukemia Immunotherapies Prostate Cancer Leukemia Oncogenes Pulmonary Fibrosis Treatment Of Acute Myeloid Leukemia Alopecia Areata

Is HCWB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.52
52 Week Low 0.2761
Average Volume 11,446,330
200-Day Moving Average 0.93
50-Day Moving Average 0.52
20-Day Moving Average 0.51
10-Day Moving Average 0.57
Average True Range 0.23
RSI (14) 65.99
ADX 31.08
+DI 61.99
-DI 11.76
Chandelier Exit (Long, 3 ATRs) 1.82
Chandelier Exit (Short, 3 ATRs) 0.98
Upper Bollinger Bands 1.02
Lower Bollinger Band -0.01
Percent B (%b) 0.93
BandWidth 203.87
MACD Line 0.09
MACD Signal Line 0.01
MACD Histogram 0.0789
Fundamentals Value
Market Cap 34.08 Million
Num Shares 36 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -1.69
Price-to-Sales 14.85
Price-to-Book 1.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.40
Resistance 3 (R3) 1.40 1.26 1.32
Resistance 2 (R2) 1.26 1.14 1.25 1.30
Resistance 1 (R1) 1.10 1.07 1.18 1.10 1.27
Pivot Point 0.96 0.96 0.99 0.95 0.96
Support 1 (S1) 0.80 0.84 0.88 0.80 0.62
Support 2 (S2) 0.66 0.77 0.65 0.60
Support 3 (S3) 0.50 0.66 0.57
Support 4 (S4) 0.50